4Siegel R,Naishadham D, jemal A. Cancer statistics, 2012[J]. CA Cancer J Clin, 2012,62 (1): 10-29.
5Abu-Rustum N R, Sonoda Y,Chi D S,et al. The effects ofCO2 pneunoperitoneum on the survival of women with persistentMetastatic ovarian cancer [J]. Gynecol Oncol, 2003,90(2): 431-434.
6Brundage M,Gropp M, Mefti F, et al. Health-related quali-ty of life in recurrent platinum-sensitive ovarian cancer-resultsfrom the CALYPSO trail [J]. Ann Oncol, 2012, 23 (8):2020-2027.
7Pujade-Lauraine E,Wagner U,Aavall-Lundqvist E,et al.Pegylated liposomal Doxorubicin and Carboplatin compared withPaclitaxel and Carboplatin for patients with platinum-sensitiveovarian cancer in late relapse [J]. J Clin Oncol, 2010,28(20): 3323-3329.
8Chase D M, Watanabe T, Monk B J. Assessment and signifi-cance of quality of life in women with gynecologic cancer [J].Future Oneol, 2010,6 (8): 1279-1287.
